Clinical Trials & Research

AZOTH Peptides – BPC-157 – RevShare (US)

MaxBounty · In-house tracking

Payout

35% of sale
Revshare

Offer details

Category

Clinical Trials & Research

Geos

US

Payout model

Revshare

Live until

No expiry

Creative preview

View preview page →
AZOTH Peptides is a premium health brand specializing in high-quality BPC-157 peptides designed to accelerate recovery, support joint health, and enhance overall physical wellness.

Converts on purchase.

Targeting: Health-conscious adults aged 25-55 in the US, including fitness enthusiasts, biohackers, athletes, and individuals seeking joint pain relief or injury recovery solutions.

Restrictions: Offers are valid for US traffic only. No incentivized traffic, no spam, no misleading ads, and no brand bidding on trademarked terms (e.g., "AZOTH", "AZOTH Peptides"). All creatives must be pre-approved, and affiliates must not make unverified medical claims. Average order value is approximately $140; accepted payment methods include major credit cards.

Network details

In-house
Tracking platform
$100
Min payout
Weekly
Payout frequency
3000
Active offers

Payment methods

ACH/Direct DepositCheckPayoneerPayPalWire

Headquarters

Ottawa, ON, Canada

Founded

2004

Similar offers under “Clinical Trials & Research”

Offer Type Payout Country
AZOTH Peptides – Triple Regulator – RevShare (US) Revshare 35% of sale US
AZOTH Peptides – NAD+ – RevShare (US) Revshare 35% of sale US
HelixALife – Research Peptides – RevShare (US) Revshare 17.5% of sale US
Search Clinical – Find Clinical Trials – MaxBounty Exclusive – Email Submit (US) Fixed $2.00 per lead US
Care Health Source – Clinical Trials – RevShare (US) Revshare 42% of sale US
Care Health Source – Clinical Trials – CPL (US) Fixed $4.00 per lead US
HealthMatch Clinical Trials – Lyme Vaccine – CPL (US) Fixed $18.75 per lead US
HealthMatch Clinical Trials – Hypertension Multi – CPL (US) Fixed $9.00 per lead US
Cognistrong – Memory Loss – CPS (US) Fixed $45.00 per lead US
HealthMatch Clinical Trials – COVID-19 Vaccine (50-64) – CPL (US) Fixed $5.25 per lead US
HealthMatch Clinical Trials – Chronic Kidney Disease – CPL (US) Fixed $56.25 per lead US